Recombinant respiratory syncytial virus pre-fusion F protein vaccine

Description

In this Product Explainer, Infectious Disease Physician and Microbiologist Prof Paul Griffin explains the role of a recombinant respiratory syncytial virus pre-fusion F protein vaccine for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).

Additional resources

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Jason Ong

Prof Jason Ong

STIs – Common and Tricky Cases

Dr Terri Foran

Dr Terri Foran

Role of Testosterone During Menopause – Evidence vs Hype

A/Prof Daryl Cheng

A/Prof Daryl Cheng

RSV Prevention in Infants and Pregnant Women

Dr Fiona Chan

Dr Fiona Chan

Vision and Driving Fitness: Key Insights for Health Practitioners

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland

Date published: 29 October 2024